McCarty scores 15, South Carolina State beats Coppin State 77-65
Published Feb. 5, 2024 10:14 p.m. ET
Associated Press
ORANGEBURG, S.C. (AP) — Caleb McCarty had 15 points in South Carolina State's 77-65 win over Coppin State on Monday night.
McCarty also had six rebounds and three blocks for the Bulldogs (8-15, 4-3 Mid-Eastern Athletic Conference). Michael Teal totaled 14 points and six rebounds. Wilson Dubinsky had 12 points on 4-for-6 shooting from 3-point range.
The Eagles (2-19, 1-6) were led by Malik Battle's 18 points. Ryan Archey scored 17 with three steals. Justin Winston contributed 15 points and seven rebounds.
___
The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
share
recommended
Last Night in College Basketball: Texas Tech Ends Their 2025 on a Roll
Tom Izzo on Pro Players Getting College Eligibility: 'Shame' on NCAA, Coaches
Top 25 college athletes with highest NIL valuations
No. 11 Vanderbilt Tops New Haven; Dores Coach Mark Byington Sets New Record
No. 2 Michigan Snaps McNeese State's Win Streak in 40-Point Rout
Jeremy Fears Jr. Scores New Career High to Lead No. 9 Michigan State Past Cornell
Top 10 men's college basketball players with highest NIL valuations
Last Night in College Basketball: BYU Freshman Star AJ Dybantsa Makes History
Item 1 of 3
recommended
Last Night in College Basketball: Texas Tech Ends Their 2025 on a Roll
Tom Izzo on Pro Players Getting College Eligibility: 'Shame' on NCAA, Coaches
Top 25 college athletes with highest NIL valuations
No. 11 Vanderbilt Tops New Haven; Dores Coach Mark Byington Sets New Record
No. 2 Michigan Snaps McNeese State's Win Streak in 40-Point Rout
Jeremy Fears Jr. Scores New Career High to Lead No. 9 Michigan State Past Cornell
Top 10 men's college basketball players with highest NIL valuations
Last Night in College Basketball: BYU Freshman Star AJ Dybantsa Makes History
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2025 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and New Privacy Policy | Advertising Choices | Your Privacy Choices | Closed Captioning
